Bio-Techne (TECH) News Today $75.83 -0.27 (-0.35%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Bio-Techne Earnings Preview: What to ExpectJanuary 20 at 12:20 PM | msn.comBio-Techne Co. (NASDAQ:TECH) Given Average Recommendation of "Moderate Buy" by AnalystsBio-Techne Co. (NASDAQ:TECH - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight brokerages that are covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and five have given a buy reJanuary 19 at 4:20 AM | marketbeat.comBio-Techne Corp (TECH) Stock ForecastsJanuary 16, 2025 | ca.finance.yahoo.comIs There Now An Opportunity In Bio-Techne Corporation (NASDAQ:TECH)?January 16, 2025 | uk.finance.yahoo.comRBC Capital Remains a Hold on Bio-Techne (TECH)January 14, 2025 | markets.businessinsider.comBio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell ...January 10, 2025 | gurufocus.comBio-Techne Corp Expands AI-Engineered Designer Protein PortfolioJanuary 10, 2025 | gurufocus.comBio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative MedicineJanuary 10, 2025 | prnewswire.comBio-Techne Corp. stock underperforms Wednesday when compared to competitors despite daily gainsJanuary 9, 2025 | marketwatch.comScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's TherapeuticsJanuary 8, 2025 | prnewswire.comBIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025January 8, 2025 | prnewswire.comBio-Techne receives favorable ruling on second Miltenyi Biotec claimJanuary 7, 2025 | markets.businessinsider.comBio-Techne Corp. stock underperforms Tuesday when compared to competitors despite daily gainsJanuary 7, 2025 | marketwatch.comBio-Techne Corp (TECH) Wins Legal Battle Against Miltenyi Biotec for Reverse EngineeringJanuary 7, 2025 | gurufocus.comBio-Techne Wins Second Claim Of Reverse Engineering By Miltenyi BiotecJanuary 7, 2025 | markets.businessinsider.comBIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTECJanuary 7, 2025 | prnewswire.comJPMorgan Chase & Co. Sells 280,782 Shares of Bio-Techne Co. (NASDAQ:TECH)JPMorgan Chase & Co. cut its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 27.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 756,184 shares of the biotechnology company's stock after selling 280,782 shares during the period. JPMorJanuary 4, 2025 | marketbeat.comBio-Techne Corp. stock underperforms Tuesday when compared to competitorsJanuary 1, 2025 | marketwatch.comBio-Techne Co. (NASDAQ:TECH) Short Interest Down 14.0% in DecemberBio-Techne Co. (NASDAQ:TECH - Get Free Report) saw a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 3,510,000 shares, a decline of 14.0% from the November 30th total of 4,080,000 shares. Based on an average daily volume of 902,200 shares, the days-to-cover ratio is presently 3.9 days.December 30, 2024 | marketbeat.comBio-Techne Corp. stock underperforms Friday when compared to competitorsDecember 27, 2024 | marketwatch.comBio-Techne Co. (NASDAQ:TECH) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Bio-Techne Co. (NASDAQ:TECH - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eight ratings firms that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and five have issued a buy rating onDecember 25, 2024 | marketbeat.comBio-Techne Corp. stock rises Tuesday, still underperforms marketDecember 24, 2024 | marketwatch.comBio-Techne Corp. stock outperforms competitors on strong trading dayDecember 20, 2024 | marketwatch.comBio-Techne signs co-marketing and co-promotion agreement with WatersDecember 20, 2024 | markets.businessinsider.comBio-Techne Corp. stock underperforms Thursday when compared to competitorsDecember 20, 2024 | marketwatch.comBIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCEDecember 20, 2024 | prnewswire.comCyclopharm Expands Technegas Footprint in U.S. MarketDecember 19, 2024 | tipranks.comYSX TECH. CO., LTD Announces Closing of Its Initial Public Offering and Full Exercise of Underwriter's Over-Allotment OptionDecember 19, 2024 | globenewswire.comBio-Techne, Waters Announce Biotherapeutic Characterization Co-marketing AgreemenentDecember 19, 2024 | markets.businessinsider.comBIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENTDecember 19, 2024 | prnewswire.comScaleReady awards a G-Rex® Grant to Moonlight BioDecember 18, 2024 | prnewswire.comYSX TECH. CO., LTD Announces Pricing of Its Initial Public OfferingDecember 17, 2024 | globenewswire.comLord Abbett & CO. LLC Has $23.73 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH)Lord Abbett & CO. LLC cut its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 10.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 296,824 shares of the biotechnology company's stock after selling 36,339 sDecember 16, 2024 | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Short Interest Up 15.6% in NovemberBio-Techne Co. (NASDAQ:TECH - Get Free Report) was the recipient of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 4,080,000 shares, a growth of 15.6% from the November 15th total of 3,530,000 shares. Based on an average daily trading volume, of 927,100 shares, the short-interest ratio is currently 4.4 days.December 15, 2024 | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Shares Sold by Toronto Dominion BankToronto Dominion Bank decreased its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 31.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 52,837 shares of the biotechnology company's stock after selling 23,993 shares during the qDecember 15, 2024 | marketbeat.comOddo BHF Asset Management Sas Purchases Shares of 14,865 Bio-Techne Co. (NASDAQ:TECH)Oddo BHF Asset Management Sas acquired a new stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 14,865 shares of the biotechnology company's stock, valued at approxiDecember 14, 2024 | marketbeat.comBarclays PLC Reduces Holdings in Bio-Techne Co. (NASDAQ:TECH)Barclays PLC trimmed its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 4.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 332,098 shares of the biotechnology company's stock after selling 14,504 shares durDecember 14, 2024 | marketbeat.comWhy Bio-Techne Corp (TECH) Is Set to Outperform the Market: Insights into Financial Growth and ...December 13, 2024 | gurufocus.comNational Bank of Canada FI Acquires 37,181 Shares of Bio-Techne Co. (NASDAQ:TECH)National Bank of Canada FI increased its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 86.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 80,436 shares of the biotechnology cDecember 13, 2024 | marketbeat.comBio-Techne signs distribution agreement with MedSanTek in TurkeyDecember 12, 2024 | markets.businessinsider.comBIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEYDecember 12, 2024 | prnewswire.comBio-Techne Corp (TECH) Launches Innovative ESR1 Mutation Monitoring AssayDecember 10, 2024 | gurufocus.comBIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAYDecember 10, 2024 | prnewswire.comWellington Management Group LLP Sells 147,797 Shares of Bio-Techne Co. (NASDAQ:TECH)Wellington Management Group LLP lowered its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 8.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,532,589 shares of the biotechnology company's stock afteDecember 10, 2024 | marketbeat.comState Street Corp Has $511.23 Million Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)State Street Corp raised its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 1.5% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 6,395,993 shares of the biotechnology company's stock after acquiring an additional 95,133 shares during thDecember 9, 2024 | marketbeat.comCyclopharm: Technegas Poised for US Market BreakthroughDecember 8, 2024 | tipranks.comTenere Capital LLC Buys 45,992 Shares of Bio-Techne Co. (NASDAQ:TECH)Tenere Capital LLC increased its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 40.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 160,245 shares of the biotechnology company's stock after purchasinDecember 8, 2024 | marketbeat.comWorldquant Millennium Advisors LLC Purchases 22,185 Shares of Bio-Techne Co. (NASDAQ:TECH)Worldquant Millennium Advisors LLC raised its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 22.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 122,934 shares of the biotechnology company's stock after purchaDecember 8, 2024 | marketbeat.comPolar Asset Management Partners Inc. Sells 23,100 Shares of Bio-Techne Co. (NASDAQ:TECH)Polar Asset Management Partners Inc. lessened its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 40.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,400 shares of the biotechnology company's stockDecember 6, 2024 | marketbeat.comJanus Henderson Group PLC Lowers Holdings in Bio-Techne Co. (NASDAQ:TECH)Janus Henderson Group PLC lowered its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 9.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 997,166 shares of the biotechnology company's sDecember 5, 2024 | marketbeat.com Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address TECH Media Mentions By Week TECH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TECH News Sentiment▼0.420.44▲Average Medical News Sentiment TECH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TECH Articles This Week▼58▲TECH Articles Average Week Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies A News Today MTD News Today WAT News Today ILMN News Today BIO News Today BRKR News Today CRL News Today PACB News Today HBIO News Today TMO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TECH) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Techne Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Techne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TECH Stock Alerts